Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy)

Atzori, Laura; Mugheddu, Cristina; Addis, Gulen; Sanna, Silvia; Satta, Rosanna; Ferreli, Caterina; Atzori, Maria Giovanna; Montesu, Ma; Rongioletti, Franco

doi:10.1111/jdv.16473

Cited by 13 publications

(19 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Some patients could not understand the crisis and demanded full attention, quite aggressively. 33 The absence of the possibility to consult a dermatologist in the usual face-to-face fashion and receive treatment recommendations has the potential to cause significant decrease of HRQoL. TD and phone consultations should be widely used and temporarily replace normal consultations except of course for emergency cases, during the pandemic.…”

Section: Patients With Skin Disease At a Risk Of Covid-19 Infectionmentioning

confidence: 99%

“…A lot of dermatologic patients were completely unprepared, upset and disoriented by the lock down. Some patients could not understand the crisis and demanded full attention, quite aggressively 33 . The absence of the possibility to consult a dermatologist in the usual face‐to‐face fashion and receive treatment recommendations has the potential to cause significant decrease of HRQoL.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic

Chernyshov

Tómas-Aragonés

Augustin

et al. 2020

Acad Dermatol Venereol

View full text Add to dashboard Cite

The pandemic of COVID-19 is a global challenge for health care, and dermatologists are not standing apart from trying to meet this challenge. The European Academy of Dermatology and Venereology (EADV) has collected recommendations from its Task Forces (TFs) related to COVID-19. The Journal of the EADV has established a COVID-19 Special Forum giving free access to related articles. The psychosocial effects of the pandemic, an increase in contact dermatitis and several other skin diseases because of stress, disinfectants and protective equipment use, especially in healthcare workers, the temporary limited access to dermatologic care, the dilemma whether or not to pause immunosuppressive therapy, and, finally, the occurrence of skin lesions in patients infected by COVID-19 all contribute to significant quality of life (QoL) impairment. Here, we present detailed recommendations of the EADV TF on QoL and patient-oriented outcomes on how to improve QoL in dermatologic patients during the COVID-19 pandemic for several different groups of patients and for the general population.

show abstract

Section: Patients With Skin Disease At a Risk Of Covid-19 Infectionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic

Chernyshov

Tómas-Aragonés

Augustin

et al. 2020

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…Moreover, these papers have published many aspects from patients' cutaneous manifestations with COVID-19 to economic impact [40] and protective measures for the cutaneous system during COVID-19 exposure [41][42][43][44][45][46][47][48][49][50][51][52]. Another aspect are skin damages in healthcare workers [42,49,[53][54][55][56][57][58], medical education and telemedicine during the pandemic [59][60][61][62], the use of immunomodulators [63,64]; immunosuppressors and immunobiological agents in dermatology [65], as well as, in rheumatology skin conditions [63,66,67].…”

Section: Introductionmentioning

confidence: 99%

Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms

et al. 2020

View full text Add to dashboard Cite

Background SARS-Cov-2 is a single-stranded RNA virus, a Betacoronavirus, composed of 16 non-structural proteins, with specific roles in replication of coronaviruses. The pathogenesis of COVID-19 is not yet fully understood. The virus and host factors interplay among distinct outcomes of infected patients. Methods Using MeSH (Medical Subject Headings) in PubMed, authors searched for articles cotaining information on COVID-19 and the skin. Results The pathophysiology of the disease is multifactorial: association with innate immune response, hypercoagulability state, lung tissue damage, neurological and/or gastrointestinal tract involvement, monocytic/macrophage activation syndrome, culminating in exaggerated cytokine secretion, called "cytokine storm", which leads to worsening and death. These systemic conditions may be associated with cutaneous lesions, that have polymorphic aspects, where at histopathological level show involvement in different skin changes. These lesions may be associated with multisystemic manifestations that could occur due to angiotensin-converting enzyme 2 receptor and transmembrane serine protease action, allowing the pulmonary infection and possibly skin manifestation. Several reports in literature show cutaneous lesions similar to chilblain, urticarial eruptions, diffuse or disseminated erythema, livedo racemosa, blue toe syndrome, retiform purpura, vesicle trunk, purpuric exanthema or exanthema with clinical aspects of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) and others. Conclusions This review describes the complexity of Covid-19, pathophysiological and clinical aspects, dermatological finding and other dermatological conditions associated with SARS-CoV-2 infection or COVID-19.

show abstract

“…1 The disease affects about 2% to 3% of the population worldwide, and its management requires qualified professionals to provide high-quality care. 2,3 Coronavirus disease (COVID-19) is a highly contagious respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 outbreak, which caused thousands of deaths, has been declared a pandemic by the World Health Organization on March 2020.…”

Section: Introductionmentioning

confidence: 99%

Psoriasis andCOVID‐19: A narrative review with treatment considerations

Elmas

Demirbaş

Kutlu

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

Coronavirus disease (COVID-19) is a highly contagious respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 outbreak has been declared a pandemic by the World Health Organization on March 2020. The pandemic has affected the management of psoriasis not only for those who are under treatment but also for those who are about to begin a new therapy to control their disease. An increasing number of studies in the current literature have focused on the relationship between psoriasis and COVID-19 from different perspectives. This narrative review includes searching the PubMed and Web of Science databases using the keywords "psoriasis," "psoriatic arthritis," "coronavirus," "COVID-19," and "SARS-CoV-2."

show abstract

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy)

Cited by 13 publications

References 3 publications

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic

Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms

Psoriasis andCOVID‐19: A narrative review with treatment considerations

Contact Info

Product

Resources

About